BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  BHR Pharma, LLC SyNAPSe® Trial Reaches Enrollment Midpoint

  July 25, 2012

   · 

  2 min read
• Business

  Actinium Pharmaceuticals, Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.

  July 25, 2012

   · 

  3 min read
• Business

  Alexion Pharmaceuticals Inc. Reports Second Quarter 2012 Results

  July 25, 2012

   · 

  1 min read
• Policy

  Verenium Corporation Announces EPA Authorization to Market Its Next-Generation Enzyme Breaker for Hydraulic Fracturing

  July 25, 2012

   · 

  4 min read
• Business

  Santarus Inc. to Hold Second Quarter 2012 Financial Results Conference Call on August 7

  July 25, 2012

   · 

  1 min read
• Drug Development

  PRA International, Inc. Participates in Landmark Alzheimer’s Prevention Clinical Trial

  July 25, 2012

   · 

  2 min read
• Policy

  Biokine Awarded FDA Orphan Drug Designation for Mobilization of Stem Cells in Cancer Patients

  July 25, 2012

   · 

  1 min read
• Business

  Questcor Pharmaceuticals, Inc. (Headquarters) Reports Second Quarter Financial Results

  July 25, 2012

   · 

  5 min read
• Biotech Bay

  Anthera Pharmaceuticals, Inc. Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock

  July 25, 2012

   · 

  3 min read
• Bio NC

  ILS Shows Dedication to Sustainability by Becoming Green Plus Certified

  July 25, 2012

   · 

  1 min read